Skip to main content
Clinical Trials/IRCT201503261760N38
IRCT201503261760N38
Completed
Phase 2

The evaluation of using Acellular Dermal Matrix Allograft (CenoDerm) together with plasma rich in growth factor in gingival augmentation

Vice Chancellor for Research and Technology, Babol University of Medical Sciences0 sites10 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Condition 1: Lack of attached gingival. Condition 2: Healing.
Sponsor
Vice Chancellor for Research and Technology, Babol University of Medical Sciences
Enrollment
10
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice Chancellor for Research and Technology, Babol University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • At least 18 years of age; The sound system; The plaque before transplantation, 25% or less; Deficient gingival bilaterally
  • Exclusion criteria:
  • Smoking; Pregnancy; There occlusal trauma; Surgical procedures were performed in the desired area in the last 12 months; Oral mucosal disease; There are more than 3 mm region of the envelope with the link; Periapical lesion; Beyond tooth mobility grade 1; Affecting periodontal medication (eg, phenytoin, oral contraceptives, estrogen and progesterone compounds, of activities and cyclosporine)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials